检索结果 - David Tesarowski

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    Associations between physical examination, laboratory, and radiographic findings and outcome and subsequent racing performance of foals with Rhodococcus equi infection: 115 cases (1984-1992)

    Associations between physical examination, laboratory, and radiographic findings and outcome and subsequent racing performance of foals with Rhodococcus equi infection: 115 cases (... 由 Dorothy M. Ainsworth, Steven W. Eicker, Amy E. Yeagar, Corinne R. Sweeney, Laurent Viel, David Tesarowski, Jean‐Pierre Lavoie, Andrew M. Hoffman, Mary Rose Paradis, Steven M. Reed, Hollis N. Erb, Elizabeth B. Davidow, Megan E. Nalevanko

    出版 1998
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  2. 2
    96O Adjuvant trastuzumab emtansine (T-DM1) vs trastuzumab (T) in patients (pts) with residual invasive disease after neoadjuvant therapy for HER2+ breast cancer: Subgroup analysis from KATHERINE

    96O Adjuvant trastuzumab emtansine (T-DM1) vs trastuzumab (T) in patients (pts) with residual invasive disease after neoadjuvant therapy for HER2+ breast cancer: Subgroup analysis... 由 Sibylle Loibl, Chiun‐Sheng Huang, Max S. Mano, T. Mamounas, Charles E. Geyer, Michael Untch, Gϋnter von Minckwitz, J-C. Thery, Ingo Schwaner, Steven Limentani, Niklas Loman, Kristina Lübbe, J. Chang, Thomas Hatschek, David Tesarowski, Thomas Boulet, Claudia Wiese, Cailu Song, Norman Wolmark

    出版 2020
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  3. 3
    Adjuvant trastuzumab emtansine in HER2-positive breast cancer patients with HER2-negative residual invasive disease in KATHERINE

    Adjuvant trastuzumab emtansine in HER2-positive breast cancer patients with HER2-negative residual invasive disease in KATHERINE 由 Sibylle Loibl, Chiun‐Sheng Huang, Max S. Mano, Eleftherios P. Mamounas, Charles E. Geyer, Michael Untch, Jean‐Christophe Théry, Ingo Schwaner, Steven Limentani, Niklas Loman, Kristina Lübbe, Jenny C. Chang, Thomas Hatschek, David Tesarowski, Chunyan Song, Sanne Lysbet de Haas, Thomas Boulet, Chiara Lambertini, Norman Wolmark

    出版 2022
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    Adjuvant T-DM1 versus trastuzumab in patients with residual invasive disease after neoadjuvant therapy for HER2-positive breast cancer: subgroup analyses from KATHERINE

    Adjuvant T-DM1 versus trastuzumab in patients with residual invasive disease after neoadjuvant therapy for HER2-positive breast cancer: subgroup analyses from KATHERINE 由 Eleftherios P. Mamounas, Michael Untch, Max S. Mano, Chiun‐Sheng Huang, Charles E. Geyer, Gϋnter von Minckwitz, Norman Wolmark, Xavier Pivot, Sherko Küemmel, Michael P. DiGiovanna, Bella Kaufman, G. Kunz, Alison Conlin, Juan Carlos Alcedo, Thorsten Kuehn, Irene Wapnir, Andrea Fontana, John Hackmann, Jonathan Polikoff, Mahasti Saghatchian, Adam Brufsky, Youngsen Yang, Martina Zimovjanová, Thomas Boulet, H. Liu, David Tesarowski, Lisa H. Lam, Chunyan Song, Melanie C. Smitt, Sibylle Loibl

    出版 2021
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  5. 5
    Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer

    Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer 由 Gϋnter von Minckwitz, Chiun‐Sheng Huang, Max S. Mano, Sibylle Loibl, Eleftherios P. Mamounas, Michael Untch, Norman Wolmark, Priya Rastogi, Andreas Schneeweiß, Andrés Redondo, Hans Holger Fischer, William Jacot, Alison Conlin, Claudia Arce-Salinas, Irene Wapnir, Christian Jackisch, Michael P. DiGiovanna, Peter A. Fasching, John Crown, P Wülfing, Zhimin Shao, Elena Rota Caremoli, Haiyan Wu, Lisa H. Lam, David Tesarowski, Melanie C. Smitt, Hannah Douthwaite, Stina Mui Singel, Charles E. Geyer

    出版 2018
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: